The Effectiveness of Continuous Glucose Monitoring in Diabetes Treatment for Infants and Young Children
NCT ID: NCT00875290
Last Updated: 2011-08-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
40 participants
INTERVENTIONAL
2008-11-30
2014-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Randomized Trial to Assess Efficacy and Safety of Continuous Glucose Monitoring in Children 4-<10 Years With T1DM
NCT00760526
Assessing Continuous Glucose Monitors in Healthy Children
NCT00069602
Strategies to Enhance New CGM Use in Early Childhood (SENCE)
NCT02912728
Randomized Study of Real-Time Continuous Glucose Monitors (RT-CGM) in the Management of Type 1 Diabetes
NCT00406133
Continuous Glucose Monitoring System Feasibility in Youth With T2D
NCT06089070
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Observational arm
No interventions assigned to this group
Real-time glucose sensor
Subjects wear real-time glucose sensor
Real-time glucose sensor
Children assigned to this intervention will use a real-time sensor continuously
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Real-time glucose sensor
Children assigned to this intervention will use a real-time sensor continuously
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Monogenic diabetes
3 Months
3 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Gerber Foundation
OTHER
Medtronic
INDUSTRY
Seattle Children's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Seattle Children's Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Patricia Fechner, MD
Role: PRINCIPAL_INVESTIGATOR
Seattle Children's Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seattle Children's Hospital
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GerberPumpStudy
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.